Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan Miguel Romero

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 26, 2023
Gender Disparities in Academic Outcomes Among Graduates of a Canadian MD-PhD ProgramJoan Miguel Romero, Mark Sorin, Matthew Dankner, et al.
Oncotarget|May 4, 2018
MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cellsRobert K Nam, Tania Benatar, Yutaka Amemiya, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|July 14, 2026
A longitudinal study of research productivity in McGill University's MD-PhD and Clinician Investigator Program Graduates from 2000 to 2017Jamie Magrill, Jean-Pierre Falet, Ella Boone, et al.
Journal of Medical Genetics|March 31, 2026
<i>ATM</i> c.7374_7375insAlu is a French-Canadian founder pathogenic variant associated with predisposition to pancreatic and breast cancerYifan Wang, Celine Domecq, Adeline Cuggia, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-AnalysisMatthew Dankner, Laurie-Rose Dubé, Mark Sorin, et al.
NPJ Precision Oncology|August 9, 2023
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancersJoan Miguel Romero, Emma Titmuss, Yifan Wang, et al.
Cell|October 13, 2021
Spatially confined sub-tumor microenvironments in pancreatic cancerBarbara T Grünwald, Antoine Devisme, Geoffroy Andrieux, et al.
Frontiers in Oncology|May 13, 2022
Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal AdenocarcinomaBryn Golesworthy, Yifan Wang, Amanda Tanti, et al.
Nature Communications|July 2, 2025
Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trialJennifer J Knox, Gun Ho Jang, Robert C Grant, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapyJoan Miguel Romero, Jamie Magrill, Nikita Kalashnikov, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 26, 2023
Gender Disparities in Academic Outcomes Among Graduates of a Canadian MD-PhD ProgramJoan Miguel Romero, Mark Sorin, Matthew Dankner, et al.
Oncotarget|May 4, 2018
MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cellsRobert K Nam, Tania Benatar, Yutaka Amemiya, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|July 14, 2026
A longitudinal study of research productivity in McGill University's MD-PhD and Clinician Investigator Program Graduates from 2000 to 2017Jamie Magrill, Jean-Pierre Falet, Ella Boone, et al.
Journal of Medical Genetics|March 31, 2026
<i>ATM</i> c.7374_7375insAlu is a French-Canadian founder pathogenic variant associated with predisposition to pancreatic and breast cancerYifan Wang, Celine Domecq, Adeline Cuggia, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-AnalysisMatthew Dankner, Laurie-Rose Dubé, Mark Sorin, et al.
NPJ Precision Oncology|August 9, 2023
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancersJoan Miguel Romero, Emma Titmuss, Yifan Wang, et al.
Cell|October 13, 2021
Spatially confined sub-tumor microenvironments in pancreatic cancerBarbara T Grünwald, Antoine Devisme, Geoffroy Andrieux, et al.
Frontiers in Oncology|May 13, 2022
Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal AdenocarcinomaBryn Golesworthy, Yifan Wang, Amanda Tanti, et al.
Nature Communications|July 2, 2025
Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trialJennifer J Knox, Gun Ho Jang, Robert C Grant, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapyJoan Miguel Romero, Jamie Magrill, Nikita Kalashnikov, et al.
Pageof 1